A Phase II Study of a Nonmyeloablative Allogeneic Stem Cell Transplant with Peritransplant Rituximab in Patients with B Cell Lymphoid Malignancies: Favorably Durable Event-Free Survival in Chemosensitive Patients
Sauter, Craig S., Barker, Juliet N., Lechner, Lauren, Zheng, Junting, Devlin, Sean M., Papadopoulos, Esperanza B., Perales, Miguel-Angel, Jakubowski, Ann A., Goldberg, Jenna D., Koehne, Guenther, CebeVolume:
20
Language:
english
Journal:
Biology of Blood and Marrow Transplantation
DOI:
10.1016/j.bbmt.2013.11.029
Date:
March, 2014
File:
PDF, 619 KB
english, 2014